Entry |
|
Name |
Cobimetinib (USAN/INN) |
Formula |
C21H21F3IN3O2
|
Exact mass |
531.0631
|
Mol weight |
531.31
|
Structure |
|
Class |
Antineoplastic
DG03137 MEK inhibitor
|
Remark |
Product (DG01825): | D10615<US> |
|
Efficacy |
Antineoplastic, Mitogen-activated extracellular signal-regulated kinase (MEK) inhibitor |
Target |
|
Pathway |
|
Interaction |
|
Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01E PROTEIN KINASE INHIBITORS
L01EE Mitogen-activated protein kinase (MEK) inhibitors
L01EE02 Cobimetinib
D10405 Cobimetinib (USAN/INN)
Drug groups [BR:br08330]
Antineoplastic
DG03137 MEK inhibitor
DG01825 Cobimetinib
D10405 Cobimetinib
Target-based classification of drugs [BR:br08310]
Protein kinases
Serine/threonine kinases
STE group
MAP2K1 (MEK1)
D10405 Cobimetinib (USAN/INN)
MAP2K2 (MEK2)
D10405 Cobimetinib (USAN/INN)
Drug groups [BR:br08330]
Antineoplastic
DG03137 MEK inhibitor
DG01825 Cobimetinib
|
Other DBs |
|
KCF data |
ATOM 30
1 C8x C 14.1897 -13.3942
2 C8y C 14.1897 -14.7916
3 C8y C 15.3999 -15.4903
4 C8y C 16.6102 -14.7916
5 C8y C 16.6102 -13.3942
6 C8x C 15.3999 -12.6955
7 C5a C 17.8390 -12.6845
8 N1y N 19.0420 -13.3789
9 O5a O 17.8387 -11.2982
10 X F 15.3999 -16.8875
11 X F 12.9796 -15.4903
12 N1b N 17.8390 -15.5013
13 C8y C 17.8390 -16.8987
14 C8x C 16.6217 -17.6016
15 C8x C 16.6218 -18.9990
16 C8y C 17.8321 -19.6976
17 C8x C 19.0494 -18.9947
18 C8y C 19.0493 -17.5973
19 X F 20.2877 -16.8820
20 X I 17.8321 -21.0800
21 C1x C 19.4055 -14.7347
22 C1z C 20.7613 -14.3712
23 C1x C 20.3978 -13.0154
24 C1y C 21.9694 -15.0684
25 N1x N 21.9697 -16.4683
26 C1x C 23.1800 -17.1667
27 C1x C 24.3901 -16.4678
28 C1x C 24.3898 -15.0679
29 C1x C 23.1794 -14.3694
30 O1a O 20.7613 -15.7686
BOND 33
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 5 7 1
8 7 8 1
9 7 9 2
10 3 10 1
11 2 11 1
12 4 12 1
13 12 13 1
14 13 14 2
15 14 15 1
16 15 16 2
17 16 17 1
18 17 18 2
19 13 18 1
20 18 19 1
21 16 20 1
22 8 21 1
23 21 22 1
24 22 23 1
25 8 23 1
26 24 22 1 #Down
27 24 25 1
28 25 26 1
29 26 27 1
30 27 28 1
31 28 29 1
32 24 29 1
33 22 30 1
|